Greco S, Made A, Mutoli M, Zhang L, Piella S, Vausort M
J Transl Med. 2023; 21(1):758.
PMID: 37884975
PMC: 10605335.
DOI: 10.1186/s12967-023-04497-6.
Madera-Sandoval R, Cerbulo-Vazquez A, Arriaga-Pizano L, Cabrera-Rivera G, Basilio-Galvez E, Miranda-Cruz P
Clin Transl Sci. 2023; 16(12):2687-2699.
PMID: 37873554
PMC: 10719476.
DOI: 10.1111/cts.13663.
Sharafi F, Esfehani R, Moodi Ghalibaf A, Jarahi L, Shamshirian A, Mozdourian M
Health Sci Rep. 2023; 6(10):e1574.
PMID: 37779668
PMC: 10533955.
DOI: 10.1002/hsr2.1574.
Aghamohamadi N, Shahba F, Mehrabadi A, Khorramdelazad H, Karimi M, Falak R
Front Endocrinol (Lausanne). 2023; 14:1139692.
PMID: 37654571
PMC: 10465349.
DOI: 10.3389/fendo.2023.1139692.
Elhag W, Elamin B, Idris E, Elsheikh A, Ghaleb K, Fallatah I
Infect Drug Resist. 2023; 16:4845-4856.
PMID: 37520449
PMC: 10386838.
DOI: 10.2147/IDR.S418629.
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles.
Di Salvatore V, Crispino E, Maleki A, Nicotra G, Russo G, Pappalardo F
Comput Struct Biotechnol J. 2023; 21:3339-3354.
PMID: 37347079
PMC: 10259169.
DOI: 10.1016/j.csbj.2023.06.007.
The unreversible reduced but persistent activated NK and CD8 T cells in severe/critical COVID-19 during omicron pandemic in China.
Qin L, Duan X, Dong J, Chang Y, Han Y, Li Y
Emerg Microbes Infect. 2023; 12(1):2208679.
PMID: 37102227
PMC: 10187090.
DOI: 10.1080/22221751.2023.2208679.
Effect of coronaviruses on blood vessel permeability: potential therapeutic targets.
Machado N, Dias K, Cortes B, Rodrigues S
Ther Adv Respir Dis. 2023; 17:17534666231162252.
PMID: 37067023
PMC: 10111163.
DOI: 10.1177/17534666231162252.
T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections.
Putter J, Seghatchian J
Cytokine. 2023; 165:156163.
PMID: 36989654
PMC: 9933323.
DOI: 10.1016/j.cyto.2023.156163.
Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.
Gospodarczyk A, Wojciechowska C, Marczewski K, Gospodarczyk N, Zalejska-Fiolka J
Medicine (Baltimore). 2023; 101(49):e31540.
PMID: 36626452
PMC: 9750607.
DOI: 10.1097/MD.0000000000031540.
Performance of D-dimer to lymphocyte ratio in predicting the mortality of COVID-19 patients.
Peng F, Yi Q, Zhang Q, Deng J, Li C, Xu M
Front Cell Infect Microbiol. 2023; 12:1053039.
PMID: 36590587
PMC: 9797859.
DOI: 10.3389/fcimb.2022.1053039.
Analysis of CT signs, radiomic features and clinical characteristics for delta variant COVID-19 patients with different vaccination status.
Wei H, Shao Z, Tai J, Fu F, Lv C, Guo Z
BMC Med Imaging. 2022; 22(1):209.
PMID: 36447133
PMC: 9832212.
DOI: 10.1186/s12880-022-00937-9.
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses.
Venkataraman S
Vaccines (Basel). 2022; 10(11).
PMID: 36366313
PMC: 9699630.
DOI: 10.3390/vaccines10111805.
Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
Gozzi-Silva S, Oliveira L, Alberca R, Pereira N, Yoshikawa F, Pietrobon A
Cells. 2022; 11(21).
PMID: 36359755
PMC: 9659290.
DOI: 10.3390/cells11213359.
Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.
Hu Q, Zhang Q, Peng C, Ma Z, Han Y
Medicine (Baltimore). 2022; 101(43):e31138.
PMID: 36316932
PMC: 9622579.
DOI: 10.1097/MD.0000000000031138.
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.
Thummler L, Konik M, Lindemann M, Fisenkci N, Koldehoff M, Gackler A
Front Immunol. 2022; 13:980698.
PMID: 36311723
PMC: 9606643.
DOI: 10.3389/fimmu.2022.980698.
Fiber-enriched botanicals: A therapeutic tool against certain metabolic ailments.
Khalid W, Arshad M, Jabeen A, Anjum F, Qaisrani T, Suleria H
Food Sci Nutr. 2022; 10(10):3203-3218.
PMID: 36249968
PMC: 9548355.
DOI: 10.1002/fsn3.2920.
Clinical characteristics and outcomes of patients with Herpes Zoster Infection in the context of SARS-CoV-2 infection. A case report and a systematic review.
Thada P, Ata F, Ali M, Affas M, Bhandari J, Sarwar S
Qatar Med J. 2022; 2022(3):41.
PMID: 36187753
PMC: 9483766.
DOI: 10.5339/qmj.2022.41.
COVID-19 disease and autoimmune disorders: A mutual pathway.
Al-Beltagi M, Saeed N, Bediwy A
World J Methodol. 2022; 12(4):200-223.
PMID: 36159097
PMC: 9350728.
DOI: 10.5662/wjm.v12.i4.200.
IL-6 drives T cell death to participate in lymphopenia in COVID-19.
Zhou X, Ye G, Lv Y, Guo Y, Pan X, Li Y
Int Immunopharmacol. 2022; 111:109132.
PMID: 35964413
PMC: 9359506.
DOI: 10.1016/j.intimp.2022.109132.